SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-071195
Filing Date
2011-03-18
Accepted
2011-03-18 16:03:21
Documents
6
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 CORTEX PHARMACEUTICALS, INC. FORM 10-K d10k.htm 10-K 1078595
2 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 1098
3 CONSENT OF HASKELL & WHITE LLP dex231.htm EX-23.1 2463
4 CERTIFICATION OF CEO - SECTION 302 dex311.htm EX-31.1 9657
5 CERTIFICATION OF CFO - SECTION 302 dex312.htm EX-31.2 9818
6 CERTIFICATION OF CEO AND CFO - SECTION 906 dex32.htm EX-32 5055
  Complete submission text file 0001193125-11-071195.txt   1107662
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16467 | Film No.: 11698396
SIC: 2834 Pharmaceutical Preparations